Ying Ying

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Transcription Factor

Ulcerative Colitis

Genome Wide Identification

Top Venues

Cell death & disease

Cancer research

Journal of agricultural and food chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Yongheng Chen, Ying Ying, Wenlong Ma, Hongchao Ma, Liang Shi, Xuefeng Gao, Min Jia, Meiqi Li, Xiaoman Song, Weixiao Kong, Wei Chen, Xiangyi Zheng, Tobias Achu Muluh, Xiaobin Wang, Maolin Wang, Xing-Sheng Shu
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression. Cancer research 84 (8) (2024)
Yongheng Chen, Ying Ying, Wenlong Ma, Hongchao Ma, Liang Shi, Xuefeng Gao, Min Jia, Meiqi Li, Xiaoman Song, Weixiao Kong, Wei Chen, Xiangyi Zheng, Tobias Achu Muluh, Xiaobin Wang, Maolin Wang, Xing-Sheng Shu
Targeting the epigenetic reader ENL inhibits super-enhancer-driven oncogenic transcription and synergizes with BET inhibition to suppress tumor progression. Cancer research (2024)
Yongheng Chen, Ying Ying, Wenlong Ma, Hongchao Ma, Liang Shi, Xuefeng Gao, Min Jia, Meiqi Li, Xiaoman Song, Weixiao Kong, Wei Chen, Xiangyi Zheng, Tobias Achu Muluh, Xiaobin Wang, Maolin Wang, Xing-Sheng Shu
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression. Cancer research 84 (8) (2024)
Yongheng Chen, Ying Ying, Maolin Wang, Canjie Ma, Min Jia, Liang Shi, Shilan Wang, Xiangyi Zheng, Wei Chen, Xing-Sheng Shu
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell death & disease 14 (1) (2023)
Yongheng Chen, Ying Ying, Maolin Wang, Canjie Ma, Min Jia, Liang Shi, Shilan Wang, Xiangyi Zheng, Wei Chen, Xing-Sheng Shu
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell death & disease 14 (1) (2023)
Yongheng Chen, Ying Ying, Maolin Wang, Canjie Ma, Min Jia, Liang Shi, Shilan Wang, Xiangyi Zheng, Wei Chen, Xing-Sheng Shu
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell death & disease 14 (1) (2023)
Yongheng Chen, Ying Ying, Maolin Wang, Canjie Ma, Min Jia, Liang Shi, Shilan Wang, Xiangyi Zheng, Wei Chen, Xing-Sheng Shu
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell death & disease 14 (1) (2023)
Yongheng Chen, Ying Ying, Maolin Wang, Canjie Ma, Min Jia, Liang Shi, Shilan Wang, Xiangyi Zheng, Wei Chen, Xing-Sheng Shu
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell death & disease 14 (1) (2023)
Ying Ying, Yi-Lin Zhang, Can-Jie Ma, Mei-Qi Li, Chao-Yue Tang, Yang-Fan Yang, Jun-Hui Zeng, Xiao-Yan Huang, Junbo Yi, Xiao-Mei Wang, Zhen-Dan He, Xing-Sheng Shu
Neuroprotective Effects of Ginsenoside Rg1 against Hyperphosphorylated Tau-Induced Diabetic Retinal Neurodegeneration via Activation of IRS-1/Akt/GSK3β Signaling. Journal of agricultural and food chemistry 67 (30) (2019)
Ying Ying, Yejun Wang, Xiaoyan Huang, Yanmei Sun, Junbao Zhang, Meiqi Li, Junhui Zeng, Maolin Wang, Wenjun Xiao, Lan Zhong, Bo Xu, Lili Li, Qian Tao, Xiaomei Wang, Xing-Sheng Shu
Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1. Oncogene 39 (5) (2019)
Huazhang Zhu, Weizhen Zhang, Yingying Zhao, Xingsheng Shu, Wencong Wang, Dandan Wang, Yangfan Yang, Zhijun He, Xiaomei Wang, Ying Ying
GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions. Molecular neurodegeneration 13 (1) (2018)